Geeta S Narayanan
Overview
Explore the profile of Geeta S Narayanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
32
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vankina S, Goyal S, Narayanan G
Rep Pract Oncol Radiother
. 2023 Oct;
28(4):565-569.
PMID: 37795231
Background: This study aimed to compare the levels of L5-S1 interspace and the bifurcation of common iliac vessels on simulation images of rectal cancer patients to evaluate the adequacy of...
2.
Goyal S, Tiwari R, Narayanan G, Narayanan S
Rep Pract Oncol Radiother
. 2022 Jan;
26(6):1003-1009.
PMID: 34992874
Background: The purpose of this study was to compare four 3D conformal radiation techniques in treatment of left breast cancer patients. Materials And Methods: Radiation was planned for 20 patients...
3.
Tiwari R, Narayanan G, Reddy V, Vishwanathan B, Narayanan S, Venugopal R
Gynecol Oncol
. 2021 Jul;
163(1):110-116.
PMID: 34304907
Methods: This comparative study included 161 patients with node-positive LACC treated with definitive chemoradiation and MRI-based brachytherapy. The prospective Boost arm accrued 71 patients to receive nodal boost either sequentially...
4.
Narayanan G, Ganesh M, Kumar R
J Cancer Res Ther
. 2021 Mar;
17(1):204-210.
PMID: 33723156
Objectives: The primary objective of this study was to compare the treatment response of cervical carcinoma patients infected with human papillomavirus (HPV) 16 and HPV 18 who are treated with...
5.
Kumar R, Narayanan G, Vishwanthan B, Narayanan S, Mandal S
Rep Pract Oncol Radiother
. 2020 Dec;
25(6):1011-1016.
PMID: 33299382
Aim: To evaluate the difference between GTVBT (Gross Tumor Volume at Brachytherapy) and HR CTV (High Risk Clinical Tumor Volume) delineated with DWI and T2W MRI. To evaluate doses to...
6.
Kumar R, Kala P, Narayanan G, Vishwanathan B, Narayanan S, Mandal S, et al.
Brachytherapy
. 2020 Sep;
20(1):112-117.
PMID: 32928683
Purpose: Image-guided adaptive brachytherapy (IGABT) recently has shown excellent clinical outcomes with superior local control and less toxicity. For IGABT, T2W (T2-weighted) MRI is the gold standard. However, studies have...
7.
Ganesh M, Narayanan G, Kumar R
Rep Pract Oncol Radiother
. 2019 Dec;
25(1):28-34.
PMID: 31866769
Background: There is no clinically applicable tumor marker for head and neck cancers. Telomerase is detected in approximately 90% of all malignant tumors, it may predict poor or favorable outcomes,...
8.
Tiwari R, Narayanan G, Narayanan S, Suresh Kumar P
Brachytherapy
. 2019 Dec;
19(1):73-80.
PMID: 31813739
Purpose: The aim of the study was to evaluate the impact of image-based combined intracavitary-interstitial brachytherapy (IC-ISBT) using a transperineal template in locally advanced cervical cancer treatment. Methods And Materials:...
9.
Tiwari R, Narayanan G, Jayakumar V, Narayanan S, Vishwanathan B, Mandal S, et al.
Gynecol Oncol
. 2018 Jul;
150(3):420-425.
PMID: 30017538
Purpose: The purpose of this series is to study the effectiveness of MRI based image-guided brachytherapy (IGBT) in Indian patients with cervical cancer who mostly present in later stages with...
10.
Rao A, Kumar R, Narayanan G
J Cancer Res Ther
. 2016 Feb;
11(4):983-5.
PMID: 26881563
We present this unusual case of cisplatin-induced acute myocardial infarction in a patient with no organic coronary artery disease (CAD), receiving chemoradiation for small cell lung cancer. Patient developed symptoms...